- Home
- SMP vs PRTA Comparison
SMP vs PRTA Comparison
Compare SMP & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMP
- PRTA
- Stock Information
- Founded
- SMP 1919
- PRTA 2012
- Country
- SMP United States
- PRTA Ireland
- Employees
- SMP N/A
- PRTA N/A
- Industry
- SMP Auto Parts:O.E.M.
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SMP Consumer Discretionary
- PRTA Health Care
- Exchange
- SMP Nasdaq
- PRTA Nasdaq
- Market Cap
- SMP 728.6M
- PRTA 802.8M
- IPO Year
- SMP N/A
- PRTA N/A
- Fundamental
- Price
- SMP $32.87
- PRTA $13.41
- Analyst Decision
- SMP Strong Buy
- PRTA Buy
- Analyst Count
- SMP 1
- PRTA 7
- Target Price
- SMP $42.00
- PRTA $57.67
- AVG Volume (30 Days)
- SMP 109.7K
- PRTA 448.2K
- Earning Date
- SMP 10-30-2024
- PRTA 11-12-2024
- Dividend Yield
- SMP 3.53%
- PRTA N/A
- EPS Growth
- SMP 1.17
- PRTA N/A
- EPS
- SMP 1.63
- PRTA N/A
- Revenue
- SMP $1,411,253,000.00
- PRTA $133,350,000.00
- Revenue This Year
- SMP $5.58
- PRTA $46.28
- Revenue Next Year
- SMP $2.30
- PRTA N/A
- P/E Ratio
- SMP $20.10
- PRTA N/A
- Revenue Growth
- SMP 2.58
- PRTA N/A
- 52 Week Low
- SMP $26.09
- PRTA $12.31
- 52 Week High
- SMP $41.71
- PRTA $41.55
- Technical
- Relative Strength Index (RSI)
- SMP 46.32
- PRTA 43.50
- Support Level
- SMP $32.68
- PRTA $12.31
- Resistance Level
- SMP $34.58
- PRTA $14.28
- Average True Range (ATR)
- SMP 0.80
- PRTA 0.98
- MACD
- SMP -0.14
- PRTA 0.00
- Stochastic Oscillator
- SMP 12.50
- PRTA 33.73
About SMP Standard Motor Products Inc.
Standard Motor Products Inc is a manufacturer and distributor of premium automotive parts used in the maintenance, service, and repair of vehicles in the automotive aftermarket industry. It operates into three business segments namely Engineered Solutions, Vehicle Control, and Temperature Control. The company focuses on the original equipment and original equipment services markets, with a product lineup of replacement parts for engine management ignition, emission, and fuel systems, as well as temperature-control products. The company operates majorly in the United States, with additional sales in Canada, Europe, Asia, Mexico, and other Latin American countries.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).